Elion Therapeutics
New York, US · Delaware corporation · 3 known investors
Biotech
Founders & leadership
JF
Jim FlynnDirector
KM
Kieren MarrExecutive Officer, Director
MH
Martin HeideckerDirector
JL
Jonathan LeffDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$25.4MraisedJun 2024 · 6 investors · BiotechnologyRule 506(b)
▶$25.4MraisedJun 2024 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim FlynnDirector
- Kieren MarrExecutive Officer, Director
- Martin HeideckerDirector
- Jonathan LeffDirector
- Offering amount
- $83.8M
- Amount sold
- $25.4M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.